Timing of Lab Work for Biweekly Testosterone Injections
For men receiving testosterone injections every 2 weeks, laboratory blood work should be drawn immediately before the next scheduled injection (trough level), which means on the same day of the week as the injection day, just prior to administering the dose.
Rationale for Trough Timing
The Endocrine Society clinical practice guideline explicitly recommends measuring "serum T levels at the end of the dosing interval just prior to the next injection and aim to achieve nadir levels in low-mid range" 1. This trough measurement strategy serves several critical purposes:
Ensures adequate dosing: The trough level represents the lowest testosterone concentration in the dosing cycle. If this nadir level falls within the therapeutic range (low-mid normal), you can be confident the patient maintains adequate testosterone throughout the entire 2-week period.
Avoids misleading peak values: Drawing labs mid-cycle or shortly after injection captures artificially elevated peak levels that don't reflect the patient's sustained testosterone exposure and may lead to inappropriate dose reductions.
Standardizes monitoring: Consistent trough timing allows for meaningful comparison between follow-up visits.
Practical Implementation
If the patient injects on Monday mornings every 2 weeks, draw labs on Monday morning before the injection (ideally the same morning, just prior to administering the dose). The timing should be:
- Fasting morning sample when possible 2
- Same day as injection day, immediately before the dose
- Approximately 14 days after the previous injection (at the end of the dosing interval)
Important Monitoring Schedule
Based on guideline recommendations 1:
- Baseline: Before starting therapy
- 3-6 months: After initiating treatment (check testosterone trough, hematocrit, PSA if indicated)
- Annually thereafter: Once stable
Common Pitfall to Avoid
The most frequent error is drawing labs at random times during the dosing cycle without documenting when the last injection occurred. This makes results uninterpretable and can lead to inappropriate dose adjustments 3. Always document the injection date, dose, and timing of blood draw relative to the injection schedule.
Alternative Consideration
If a patient experiences late-cycle symptom recurrence (fatigue, reduced libido) despite adequate trough levels, or early-cycle symptoms (acne, mood changes, fluid retention) suggesting excessive peak levels, this indicates the every-2-week interval may be creating too much peak-trough variation 3. In such cases, consider more frequent dosing (weekly or twice-weekly) with proportionally reduced doses rather than simply increasing the total dose.